Balyasny Asset Management

Balyasny Asset Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Balyasny Asset Management’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$16.1M	Buy
2025 Q1	–	Sell
2024 Q4	$2.94M	Sell
2024 Q3	$10.9M	Sell
2024 Q2	$9.24M	Buy
2024 Q1	$2.88M	Buy